Loading...
For more than 100 years, it has been known that high doses of aspirin lower blood glucose concentrations. Investigators at Harvard and the University of California, San Diego, have identified the chemical pathway that is involved, at least in rodents.
In rodent models of insulin resistance and hyperglycemia (particularly in ob/ob mice), the team demonstrated that constant infusions of high-dose aspirin (or sodium salicylate) lowered fasting blood glucose levels, improved glucose tolerance, increased insulin-receptor activity, and lowered triglyceride and free fatty acid levels.
In studies with cultured fat cells, the investigators demonstrated that salicylates inhibited a molecule called IκB kinase β (IKKβ). The investigators then bred mice t…